Skip to content

Medical Cannabis and Breast Cancer

Medical Cannabis and Breast Cancer

October is breast cancer awareness month and we at Arfinn Med would like to reiterate the importance of early screening and regular tests.  According to the American Cancer Society:

“Breast cancer is the most common cancer in American women, except for skin cancers. Currently, the average risk of a woman in the United States developing breast cancer sometime in her life is about 13%. This means there is a 1 in 8 chance she will develop breast cancer. This also means there is a 7 in 8 chance she will never have the disease.”

Though more studies are needed, we wanted to share some current research about medical marijuana and how it can possibly help breast cancer patients.

According to Virginia F. Borges, M.D., MMSc., professor of medicine and director of the Breast Cancer Research Program at the University of Colorado Cancer Center, she finds that cannabis can help improve some of the symptoms associated the breast cancer treatment.

“I’ve mainly seen it used in conjunction with prescription drugs to control pain and other side effects in patients living with metastatic disease,” she said. “It’s rare that a person living with metastatic breast cancer would have only one side effect to manage. So, by adding in medical marijuana, it often allows me to cut back on the number of drugs I prescribe. With a high-quality source for medical marijuana and knowing how it affects an individual, using medical marijuana can put more control back in the hands of my patient. If someone is feeling good, she may only need to take one or two drops per day. If she’s not feeling good, she may need three or four drops per day. Many of the prescription drugs don’t have this flexibility. Any time you can give control back to a person when their living with cancer, it’s a good thing.”

In addition to helping with the side effects of treatment, some research has shown the ability for cannabidiol (CBD) to actually treat breast cancer itself.  A study published in the journal Molecular Cancer Therapeutics found CBD to be very helpful in inhibiting aggressive cancer cells.

“In the study the team led by senior scientist Dr. Sean D. McAllister used CBD to inhibit the activity of the Id-1 gene, believed to be responsible for cancer cells becoming more aggressive and metastatic. “Metastasis is the final and fatal step in the progression of breast cancer,” the authors write. “Currently available therapeutic strategies at this stage of cancer progression are often nonspecific, have only marginal efficacy and are highly toxic.”

Though cannabinoid medicine has been shown to help with some aspects of breast cancer and the resulting treatment side effects, more research is needed to truly understand its role in the recovery of breast cancer patients.  We hope that as the stigma of medical marijuana disappears, research will be easier to conduct.

In the meantime, please get regular screenings and encourage others to do as well!

Resources:

https://www.breastcancer.org/treatment/comp_med/types/medical-marijuana

https://health.usnews.com/health-care/patient-advice/articles/2017-09-05/can-marijuana-help-with-breast-cancer

https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html

Stories you may be interested in

Scientists Discover Two New Cannabinoids

The plant Cannabis sativa produces more than 400 chemicals, but only one, THC, gets you high. Or so it seems. A group of Italian researchers announced on December 30th the discovery of two new cannabinoids, chemicals produced by weed like THC and CBD. The first, tetrahydrocannabiphorol (THCP), is allegedly 30 times more potent than THC, they claim.…
Read More

States with medical marijuana laws saw 20 percent drop in some opioid prescriptions

States with active medical marijuana laws saw certain opioid prescription rates drop nearly 20 percent compared to states without medical marijuana programs, according to a first-of-its-kind study out of Columbia University’s Irving Medical Center. Authors said the findings underscore the importance of providing patients with pain management alternatives, such as cannabis, in efforts to reduce…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

Medical Marijuana and Cancer

September is dedicated to recognizing numerous cancers that many around the world suffer from, including prostate, thyroid, ovarian and blood cancers. These cancers and many others can produce life-debilitating symptoms and conditions that are difficult to treat with traditional medications. Although there might not be one ‘perfect fix’ when it comes to curing cancer, medical…
Read More

CEO Spotlight: James West

As a former academic coordinator for the City University of New York Research Foundation and Medgar Evers College, CEO and co-founder of Arfinn Med, James West, has extensive experience in adult education and professional training programming. James put this extensive education to good use when he noticed that there was a direct need for a…
Read More

$2.7 million awarded for medical marijuana research in Colorado

The state has awarded $2.7 million for research into how medical marijuana could replace opioids to ease chronic spinal pain — and how it might treat irritability in children and adolescents with autism. Read the full story here.
Read More

Leave a Comment

You must be logged in to post a comment.